La Chaux-de-Fonds, Switzerland

Antoine Attinger

This inventor holds 4 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Glenmark Pharmaceuticals S.a., Ichnos Sciences Sa. Active years: 2014-2025.

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Antoine Attinger from La Chaux-de-Fonds, CH

Introduction

Antoine Attinger, an accomplished inventor based in La Chaux-de-Fonds, Switzerland, has made significant strides in the field of biotechnology. With a total of four patents to his name, he has shown remarkable dedication to advancing medical science through his innovative work.

Latest Patents

Attinger's latest patents focus on the development of antibodies that bind to OX40 and their respective uses. The primary invention revolves around antagonist antibodies or fragments that specifically target human OX40. This innovation details the composition of the antibodies, including specific heavy and light chain complementary determining regions (CDRs) identified by their unique amino acid sequences. This discovery has potential implications in therapeutic applications, as it is instrumental in understanding immune responses.

Career Highlights

Throughout his career, Antoine Attinger has worked with notable companies in the pharmaceutical industry, including Glenmark Pharmaceuticals S.A. and Ichnos Sciences S.A. His experiences in these organizations have contributed significantly to his expertise and the successful development of his patents.

Collaborations

Antoine has collaborated with talented individuals such as Stanislas Blein and Jonathan Albert Back. Their teamwork likely fostered an environment of innovation and idea exchange, enhancing the development of his groundbreaking inventions.

Conclusion

Antoine Attinger is a prominent figure in the realm of biotech innovation, particularly with his work related to OX40-targeting antibodies. His contributions not only reflect his ingenuity but also pave the way for future advancements in medical treatments, showcasing the vital role inventors play in shaping the future of healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…